In the BioHarmony Drug Report Database

"Preview" Icon

Sufentanil

Dsuvia, Sufenta, Dzuveo, Zalviso (sufentanil) is a small molecule pharmaceutical. Sufentanil was first approved as Dsuvia on 1984-05-04. It is used to treat pain in the USA. It has been approved in Europe to treat pain and postoperative pain. The pharmaceutical is active against mu-type opioid receptor. Sufentanil citrate’s patents are valid until 2031-07-29 (FDA).

 

Trade Name

 

Dzuveo, Zalviso
 

Common Name

 

sufentanil
 

ChEMBL ID

 

CHEMBL658
 

Indication

 

pain, postoperative pain
 

Drug Class

 

Narcotic analgesics (fentanyl derivatives)

Image (chem structure or protein)

Sufentanil structure rendering